Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2004 | 12-2003 | 09-2003 | 06-2003 | 03-2003 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 75,089 | 23,468 | N/A | N/A | N/A |
Marketable Securities | 3,556 | 5,629 | N/A | N/A | N/A |
Receivables | 2,780 | 220 | N/A | N/A | N/A |
TOTAL | $82,616 | $30,739 | $N/A | $N/A | $N/A |
Non-Current Assets | |||||
PPE Net | 734 | 828 | N/A | N/A | N/A |
Other Non-Current Assets | 435 | 18 | 0 | 0 | 0 |
TOTAL | $1,169 | $846 | $N/A | $N/A | $N/A |
Total Assets | $83,785 | $31,585 | $N/A | $N/A | $N/A |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 2,036 | 1,410 | 0 | 0 | 0 |
Accrued Expenses | 3,579 | 2,989 | N/A | N/A | N/A |
TOTAL | $7,365 | $4,399 | $N/A | $N/A | $N/A |
Non-Current Liabilities | |||||
Deferred Revenues | 1,750 | N/A | N/A | N/A | N/A |
Other Non-Current Liabilities | 0 | 98,368 | 0 | 0 | 0 |
TOTAL | $6,750 | $99,118 | $N/A | $N/A | $N/A |
Total Liabilities | $14,115 | $103,517 | $N/A | $N/A | $N/A |
Shareholders' Equity | |||||
Shares Outstanding, K | 2,461 | N/A | N/A | N/A | N/A |
Common Shares | 25 | 2 | N/A | N/A | N/A |
Retained earnings | -83,231 | -79,365 | N/A | N/A | N/A |
Other shareholders' equity | -5,565 | -5,331 | 0 | 0 | 0 |
TOTAL | $69,670 | $-71,932 | $N/A | $N/A | $N/A |
Total Liabilities And Equity | $83,785 | $31,585 | $0 | $0 | $0 |